An integrated landscape of protein expression in human cancer
暂无分享,去创建一个
Andrew F. Jarnuczak | A. Brazma | I. Papatheodorou | J. Vizcaíno | Yasset Pérez-Riverol | D. J. Kundu | F. Ghavidel | H. Najgebauer | Mitra Barzine
[1] E. Schaafsma,et al. Faculty Opinions recommendation of CELLector: Genomics-Guided Selection of Cancer In Vitro Models. , 2020, Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature.
[2] MAGE-TAB , 2020, Definitions.
[3] Evan G. Williams,et al. Multi-omic measurements of heterogeneity in HeLa cells across laboratories , 2019, Nature Biotechnology.
[4] Juan Antonio Vizcaíno,et al. The functional landscape of the human phosphoproteome , 2019, Nature Biotechnology.
[5] Martin Eisenacher,et al. The PRIDE database and related tools and resources in 2019: improving support for quantification data , 2018, Nucleic Acids Res..
[6] Jacob D. Jaffe,et al. Next-generation characterization of the Cancer Cell Line Encyclopedia , 2019, Nature.
[7] S. Janes,et al. The secret lives of cancer cell lines , 2018, Disease Models & Mechanisms.
[8] Jian Wang,et al. Assembling the Community-Scale Discoverable Human Proteome , 2018, Cell systems.
[9] Joshua M. Dempster,et al. Genetic and transcriptional evolution alters cancer cell line drug response , 2018, Nature.
[10] Mathias Wilhelm,et al. A deep proteome and transcriptome abundance atlas of 29 healthy human tissues , 2018, bioRxiv.
[11] Peter W. Laird,et al. Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer , 2018, Cell.
[12] C. Sander,et al. A Landscape of Metabolic Variation across Tumor Types. , 2018, Cell systems.
[13] Francesco Iorio,et al. CELLector: Genomics Guided Selection of Cancer in vitro Models , 2018, bioRxiv.
[14] Nuno A. Fonseca,et al. Expression Atlas: gene and protein expression across multiple studies and organisms , 2017, Nucleic Acids Res..
[15] Thawfeek M. Varusai,et al. The Reactome Pathway Knowledgebase , 2017, Nucleic acids research.
[16] Heiner Koch,et al. Pharmacoproteomic characterisation of human colon and rectal cancer , 2017, Molecular systems biology.
[17] Daniel C. Liebler,et al. Colorectal Cancer Cell Line Proteomes Are Representative of Primary Tumors and Predict Drug Sensitivity. , 2017, Gastroenterology.
[18] Patricia Greninger,et al. Detection of Dysregulated Protein Association Networks by High-Throughput Proteomics Predicts Cancer Vulnerabilities , 2017, Nature Biotechnology.
[19] Karina D. Sørensen,et al. An Optimized Shotgun Strategy for the Rapid Generation of Comprehensive Human Proteomes , 2017, Cell systems.
[20] Claire D. McWhite,et al. Integration of over 9,000 mass spectrometry experiments builds a global map of human protein complexes , 2017, Molecular systems biology.
[21] Lennart Martens,et al. A Golden Age for Working with Public Proteomics Data , 2017, Trends in biochemical sciences.
[22] Alexander Lex,et al. UpSetR: an R package for the visualization of intersecting sets and their properties , 2017, bioRxiv.
[23] Yiling Lu,et al. Characterization of Human Cancer Cell Lines by Reverse-phase Protein Arrays. , 2017, Cancer cell.
[24] Rodrigo Dienstmann,et al. Genomic Determinants of Protein Abundance Variation in Colorectal Cancer Cells , 2016, bioRxiv.
[25] Ruedi Aebersold,et al. Mass-spectrometric exploration of proteome structure and function , 2016, Nature.
[26] M. Mann,et al. Integrative proteomic profiling of ovarian cancer cell lines reveals precursor cell associated proteins and functional status , 2016, Nature Communications.
[27] Guanglong Jiang,et al. Comprehensive comparison of molecular portraits between cell lines and tumors in breast cancer , 2016, BMC Genomics.
[28] Peter K. Sorger,et al. Conservation of protein abundance patterns reveals the regulatory architecture of the EGFR-MAPK pathway , 2016, Science Signaling.
[29] Hans Clevers,et al. Modeling Development and Disease with Organoids , 2016, Cell.
[30] Ronald J. Moore,et al. Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer , 2016, Cell.
[31] Pär Stattin,et al. The Proteome of Primary Prostate Cancer. , 2016, European urology.
[32] R. Aebersold,et al. On the Dependency of Cellular Protein Levels on mRNA Abundance , 2016, Cell.
[33] Eytan Ruppin,et al. System-wide Clinical Proteomics of Breast Cancer Reveals Global Remodeling of Tissue Homeostasis. , 2016, Cell systems.
[34] M. Mann,et al. Proteomic maps of breast cancer subtypes , 2016, Nature Communications.
[35] J. Vizcaíno,et al. Exploring the potential of public proteomics data , 2015, Proteomics.
[36] Laura M. Heiser,et al. Tumor-Derived Cell Lines as Molecular Models of Cancer Pharmacogenomics , 2015, Molecular Cancer Research.
[37] Subha Madhavan,et al. The CPTAC Data Portal: A Resource for Cancer Proteomics Research. , 2015, Journal of proteome research.
[38] A. Lamond,et al. Multidimensional proteomics for cell biology , 2015, Nature Reviews Molecular Cell Biology.
[39] Matthew E. Ritchie,et al. limma powers differential expression analyses for RNA-sequencing and microarray studies , 2015, Nucleic acids research.
[40] Su-In Lee,et al. The Proteomic Landscape of Triple-Negative Breast Cancer. , 2015, Cell reports.
[41] Paul Theodor Pyl,et al. HTSeq—a Python framework to work with high-throughput sequencing data , 2014, bioRxiv.
[42] Jeffrey R. Whiteaker,et al. Proteogenomic characterization of human colon and rectal cancer , 2014, Nature.
[43] B. Kuster,et al. Mass-spectrometry-based draft of the human proteome , 2014, Nature.
[44] G. Getz,et al. Inferring tumour purity and stromal and immune cell admixture from expression data , 2013, Nature Communications.
[45] Mathias Wilhelm,et al. Global proteome analysis of the NCI-60 cell line panel. , 2013, Cell reports.
[46] C. Sander,et al. Evaluating cell lines as tumour models by comparison of genomic profiles , 2013, Nature Communications.
[47] Simen Myhre,et al. Influence of DNA copy number and mRNA levels on the expression of breast cancer related proteins , 2013, Molecular oncology.
[48] A. Brazma,et al. Reuse of public genome-wide gene expression data , 2012, Nature Reviews Genetics.
[49] Sridhar Ramaswamy,et al. Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells , 2012, Nucleic Acids Res..
[50] Cole Trapnell,et al. TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions , 2013, Genome Biology.
[51] M. Mann,et al. Comparative Proteomic Analysis of Eleven Common Cell Lines Reveals Ubiquitous but Varying Expression of Most Proteins* , 2012, Molecular & Cellular Proteomics.
[52] Matko Bosnjak,et al. REVIGO Summarizes and Visualizes Long Lists of Gene Ontology Terms , 2011, PloS one.
[53] M. Selbach,et al. Global quantification of mammalian gene expression control , 2011, Nature.
[54] Mehdi Mirzaei,et al. Less label, more free: Approaches in label‐free quantitative mass spectrometry , 2011, Proteomics.
[55] Cole Trapnell,et al. Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. , 2010, Nature biotechnology.
[56] H. Parkinson,et al. A global map of human gene expression , 2010, Nature Biotechnology.
[57] Israel Steinfeld,et al. BMC Bioinformatics BioMed Central , 2008 .
[58] M. Mann,et al. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification , 2008, Nature Biotechnology.
[59] Joachim Selbig,et al. pcaMethods - a bioconductor package providing PCA methods for incomplete data , 2007, Bioinform..
[60] Paul T. Spellman,et al. A simple spreadsheet-based, MIAME-supportive format for microarray data: MAGE-TAB , 2006, BMC Bioinformatics.
[61] Pablo Tamayo,et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[62] R. Sandberg,et al. Assessment of tumor characteristic gene expression in cell lines using a tissue similarity index (TSI). , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[63] M. Daly,et al. PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes , 2003, Nature Genetics.